Are Mitochondria a Potential Target for Treating β-Thalassemia?
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(4), P. 1095 - 1095
Published: Feb. 8, 2025
The
inherited
genetic
disorder
β-thalassemia
affects
the
hematopoietic
system
and
is
caused
by
low
production
or
absence
of
adult
hemoglobin
(HbA).
Ineffective
erythropoiesis
hallmark
pathophysiology
characterized
an
erythropoietin-driven
substantial
increase
in
erythroblast
proliferation,
coupled
with
late-stage
precursor
apoptosis,
which
results
levels
circulating
mature
red
blood
cells
(RBCs)
chronic
anemia.
Mitochondrial
dysfunction
commonly
occurs
these
because
increased
demand
for
energy
need
to
manage
abnormal
chain
synthesis.
Moreover,
several
studies
have
highlighted
importance
gradual
mitochondrial
clearance
erythroid
cell
production.
This
review
offers
overview
role
essential
cellular
processes,
particularly
those
crucial
maintaining
RBC
health
function.
Additionally,
recent
evidence
regarding
contribution
severity
discussed,
along
updated
insights
into
indirect
mitochondria-targeting
treatments,
present
potential
pharmacological
targets.
Language: Английский
Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts
Haodong Liu,
No information about this author
Chunting Peng,
No information about this author
Qisheng Su
No information about this author
et al.
Annals of Hematology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
Hemoglobin
H
Disease-Constant
Spring
(HbH-CS)
represents
a
severe
variant
of
α-thalassemia
characterized
by
fundamental
pathological
mechanism
involving
inadequate
synthesis
α-globin
chains.
This
deficiency
results
in
the
formation
unstable
(HbH)
due
to
aggregation
free
β-globin
chains,
which
subsequently
induces
an
imbalance
oxidative
stress
within
erythrocytes.
leads
abnormal
accumulation
reactive
oxygen
species
(ROS),
turn
promotes
lipid
peroxidation,
culminating
production
malondialdehyde
(MDA)
and
significant
depletion
glutathione
(GSH).
Concurrently,
Nrf2
is
translocated
nucleus,
where
it
activates
antioxidant
response
element
(ARE)
mitigate
cellular
stress.
Here,
we
report
that
NSUN3
(which,
together
with
ALKBH1,
maintains
mitochondrial
function
through
m5C→f5C
modification)
abnormally
overexpressed
reticulocytes
from
patients
HbH-CS,
vitro
model
overexpression/silencing
was
constructed
using
K562
cells,
have
potential
for
erythroid
lineage
differentiation
retain
intact
cluster
bead
protein
genes.
Functional
assays
indicated
overexpression
significantly
intensified
intracellular
ROS
MDA,
led
reduction
GSH
levels,
diminished
overall
capacity
(T-AOC).
may
be
resulting
inhibition
respiratory
chain
complex
I,
II,
IV
aberrant
modification.
In
addition,
further
exacerbates
inhibiting
phosphorylation
hindering
its
translocation
into
nucleus
weakening
system.
Moreover,
also
observed
exacerbated
DNA
damage
inhibited
value-added
activity,
silencing
showed
opposite
result.
Our
research
offers
initial
insights
molecular
mechanisms
modulates
erythrocytes
via
role
epigenetic
modifications.
These
findings
contribute
deeper
understanding
clinical
management
Hb
H-CS.
Language: Английский
Integrative analysis of copper dysregulation and cuproptosis in postnatal hematopoiesis
Science Bulletin,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 1, 2025
Language: Английский
Beyond ATP: Metabolite Networks as Regulators of Physiological and Pathological Erythroid Differentiation
Axel Joly,
No information about this author
Arthur Schott,
No information about this author
Ira Phadke
No information about this author
et al.
Physiology,
Journal Year:
2024,
Volume and Issue:
40(1), P. 88 - 101
Published: Sept. 3, 2024
Hematopoietic
stem
cells
(HSCs)
possess
the
capacity
for
self-renewal
and
sustained
production
of
all
mature
blood
cell
lineages.
It
has
been
well
established
that
a
metabolic
rewiring
controls
switch
HSCs
from
state
to
more
differentiated
state,
but
it
is
only
recently
we
have
appreciated
importance
pathways
in
regulating
commitment
progenitors
distinct
hematopoietic
In
context
erythroid
differentiation,
an
extensive
network
metabolites,
including
amino
acids,
sugars,
nucleotides,
fatty
vitamins,
iron,
required
red
(RBC)
maturation.
this
review,
highlight
multifaceted
roles
via
which
metabolites
regulate
physiological
erythropoiesis
as
effects
perturbations
on
lineage
differentiation.
Of
note,
differentiation
process
associated
with
exceptional
breadth
solute
carrier
(SLC)
metabolite
transporter
upregulation.
Finally,
discuss
how
recent
research,
revealing
critical
impact
reprogramming
diseases
disordered
ineffective
erythropoiesis,
created
opportunities
development
novel
metabolic-centered
therapeutic
strategies.
Language: Английский